Study Tool
Apart from the demographic characteristics of patients, our own survey study consisting of 25 questions was planned. The survey was designed by the doctor as a Turkish native language. The survey consisting of 25 questions in total was outlined in 3 sections. In the first section, patients were asked general information about COVID-19. In the second section, questions were raised about their thoughts on prevention methods. In the third part, questions were asked about the COVID-19 outbreak and cancer. Except for 2 questions in the survey, the answers were designed to consist of 3 options. In order to be easy and clear, the majority of options were created as ”yes, no or not sure”. Knowledge on the subject of COVID-19 was evaluated by answering 11 multiple-choice questions followed by the calculation of a total cumulative knowledge score for every contributor. Questions were given one point for correct response and zero point for incorrect answers or unsure answers. The maximum score was 11, and the minimum was 0. Interviews were conducted in the outpatient room taking into account the rules of pandemic isolation and social distance with patients applying for routine control or treatment process. The purpose of the study and absolute confidentiality of personal information was explained to the patients by the attending physician. Patients who were over 18 years of age, who had normal intelligence levels as clinical observation and who did not have organic brain syndrome, who were not in the terminal period of cancer, and who agreed to the study were included in the study. Individuals with brain metastasis or primary brain tumors were not included in the study.